Dona Fleishaker

Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study

Désirée van der Heijde, Atul Deodhar, James Cheng‐Chung Wei et al. · Annals of the Rheumatic Diseases · 2017 · 369 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

Atul Deodhar, Paula Śliwińska-Stańczyk, Huji Xu et al. · Annals of the Rheumatic Diseases · 2021 · 248 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +10

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

Jennifer Hammond, Robert J. Fountaine, Carla Yunis et al. · New England Journal of Medicine · 2024 · 135 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial

Dona Fleishaker, Juan A. García Meijide, Michael Kohen et al. · Arthritis Research & Therapy · 2012 · 68 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children

Kenneth L. Wible, Miguel Tregnaghi, Jon Bruss et al. · The Pediatric Infectious Disease Journal · 2003 · 62 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14